I subscribe to multiple services and have seen quite a few recommendations for gene editing stocks (CRSP, BEAM, EDIT, etc). Is there some movement in this space? I bought these things 2 years ago and not much has happened.
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
I am up:
CRSP – 38% in 4 years, on Feb 2021 I was up 150%!
I sold EDIT and I have been wary of these gene editing investments for a while.
Yes, there seems to be a bit of upward movement in the stocks you mentioned, but the turnaround applies to all sectors at this point due to the overdone sell-off last month.
It might be worth noting, however, that Doc Eifrig’s freebie reco during Stansberry’s most recent webinar (titled “2022 Kickoff”, aired Jan 27th) was Pfizer — not for the vaccines but for its partnership with Beam to test a newer form of gene editing.